CD19-免疫PET用于B细胞淋巴瘤患者的CD19表达的非侵入性可视化

Dominik Sonanini1,2,3, Johannes Schwenck4,5,6, Simone Blaess4

  • 1Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Röntgenweg 13, 72076, Tübingen, Germany. dominik.sonanini@med.uni-tuebingen.de.

Biomarker research
|May 12, 2024
PubMed
概括

这项研究引入了64Cu-alphaCD19免疫oPET,用于在B细胞非霍奇金淋巴瘤 (B-NHL) 中非侵入性可视化CD19表达. 这种新的成像工具揭示了异质抗原表达,可能引导个性化的CD19导向疗法.

相关概念视频